Skip to content
Search

Latest Stories

Indian Origin Man Jailed In UK For Illegal Supply Of Medicines

Indian origin man Jagdiep Dhonsi is one among the three jailed in the UK for his involvement in the illegal supply of potentially dangerous prescription-only medicines.

Jagdiep Dhonsi, Amrin Mirza and Shirina Ali were sentenced on Monday (7) at Southwark Crown Court for their involvement in the crime.


Dhonsi was sentenced to 38 months imprisonment, Mirza to 18 months imprisonment, and Ali to 9 months imprisonment for their roles in the crimes.

Following a complex investigation, the Medicines and Healthcare products Regulatory Agency (MHRA) seized more than 300,000 tablets, worth in excess of £315,000.

It is believed these tablets seized represent a fraction of the overall illegal operation.

The trio were convicted of conspiracy to supply unauthorised medicines, including diazepam, zolpidem and zopiclone which are also controlled under the Misuse of Drugs Act, together with other powerful prescription-only medicines.

The supply of medicines from sources outside the regulated supply chain represents a significant public health risk and the criminal group responsible showed a complete disregard for the public’s safety and well-being.

The medicines the group were supplying can have serious side effects; such as, finasteride, which is used to treat hair loss, can lead to foetal abnormalities and sibutramine, which is used as an appetite suppressant was banned in 2010 because of the health risks associated with its use which include cardiovascular events such as heart attack and stroke.

Alastair Jeffrey, MHRA Head of Enforcement said, “Medicines purchased outside the regulated supply chain cannot be guaranteed to meet standards of quality, safety and effectiveness and can present a real risk to public health. Some may contain dangerous ingredients which can have devastating consequences for patients who use them.

“We work to identify those involved in illegal activities with medicines and will use our powers to investigate fully, confiscate assets and, where necessary, prosecute those putting profit before public health,” he added.

More For You

Reliance IPO

Bankers are proposing a valuation of as much as $170 bn for Jio

Getty Images

Reliance begins work for India's largest IPO

Highlights

  • Reliance Industries starts preparing draft prospectus for Jio Platforms listing.
  • Bankers propose valuation of up to $170 bn, surpassing rival Bharti Airtel's $140 bn.
  • IPO could raise $4.3 bn under new SEBI rules, potentially launching in first half of 2026.
Reliance Industries has begun work on an initial draft prospectus for the listing of Jio Platforms, in what is expected to be India's biggest-ever initial public offering, Bloomberg reported Thursday citing people familiar with the development.

The oil-to-telecoms conglomerate is informally speaking with banks to prepare a prospectus that it plans to file with the regulator as soon as possible, said the sources, who requested anonymity as the process remains private.

The draft prospectus filing and formal appointment of bankers will occur after new rules on Indian IPOs come into effect. The Securities and Exchange Board of India (SEBI) has approved reducing the minimum dilution in IPOs to as low as 2.5 per cent for companies with a post-issue market capitalisation above 5 trillion rupees ($55 bn), though the change has not yet been implemented.

Keep ReadingShow less